Who
Adam Schayowitz
EVP, Head of R&D
Company insider
Files Form 4 as: EVP, Head of R&D, Zymeworks.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $358K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Apr 2026
- Last trade
- 9 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 9 Oct 2026 | ZYME ZymeworksBiotechnology | SEC FORM 4 Code M | —37,037 at $0.00 | filing |
| 9 Oct 2026filed 9 Oct 2026 | ZYME ZymeworksBiotechnology | SEC FORM 4 Sold | $358K13,832 at $25.85 | filing |
| 9 Oct 2026filed 9 Oct 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,037 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,000 at $0.00 | filing |
| 9 Apr 2026filed 10 Apr 2026 | ZYME Zymeworksoption or derivative · Biotechnology | SEC FORM 4 Code A | —76,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.